Jefferies Financial Group Inc. Argenx Se Put Options Transaction History

Jefferies Financial Group Inc.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$434.22 - $551.9 $65.1 Million - $82.8 Million	150,000 Added 1666.67%	159,000 $86.2 Million
Q1 2024 May 13, 2024	SELL	$356.95 - $413.29 $1.25 Million - $1.45 Million	-3,500 Reduced 28.0%	9,000 $3.54 Million
Q4 2023 Feb 13, 2024	BUY	$338.91 - $506.01 $4.24 Million - $6.33 Million	12,500 New	12,500 $4.76 Million
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $468,182 - $549,354	1,300 New	1,300 $506,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.5B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.